B. Riley Has Negative Outlook for InfuSystem Q2 Earnings

InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) - Equities researchers at B. Riley reduced their Q2 2025 EPS estimates for shares of InfuSystem in a research report issued on Tuesday, March 4th. B. Riley analyst K. Bauser now anticipates that the company will earn $0.05 per share for the quarter, down from their prior forecast of $0.06. The consensus estimate for InfuSystem's current full-year earnings is $0.15 per share. B. Riley also issued estimates for InfuSystem's FY2025 earnings at $0.23 EPS.

Separately, StockNews.com downgraded shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a report on Thursday.

InfuSystem Stock Performance

NYSE:INFU traded down $0.47 on Thursday, reaching $5.64. 351,153 shares of the company's stock were exchanged, compared to its average volume of 112,959. The firm has a market cap of $119.93 million, a price-to-earnings ratio of 94.02 and a beta of 1.75. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The stock has a fifty day simple moving average of $7.92 and a 200-day simple moving average of $7.59. InfuSystem has a 52 week low of $5.28 and a 52 week high of $9.97.

Institutional Investors Weigh In On InfuSystem

Several hedge funds and other institutional investors have recently modified their holdings of INFU. BNP Paribas Financial Markets increased its holdings in InfuSystem by 66.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company's stock worth $27,000 after acquiring an additional 1,626 shares during the period. Barclays PLC boosted its stake in InfuSystem by 10.1% during the fourth quarter. Barclays PLC now owns 31,479 shares of the company's stock valued at $266,000 after buying an additional 2,882 shares during the period. State Street Corp grew its position in InfuSystem by 1.1% during the third quarter. State Street Corp now owns 267,012 shares of the company's stock worth $1,789,000 after buying an additional 3,019 shares in the last quarter. Wells Fargo & Company MN increased its stake in InfuSystem by 51.7% in the 4th quarter. Wells Fargo & Company MN now owns 9,286 shares of the company's stock worth $78,000 after acquiring an additional 3,165 shares during the last quarter. Finally, Millennium Management LLC raised its holdings in shares of InfuSystem by 6.3% in the 4th quarter. Millennium Management LLC now owns 76,419 shares of the company's stock valued at $646,000 after acquiring an additional 4,532 shares in the last quarter. 71.13% of the stock is currently owned by institutional investors.

Remove Ads

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.